Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
2.560
+0.040 (1.59%)
At close: Aug 1, 2025, 4:00 PM
2.650
+0.090 (3.52%)
After-hours: Aug 1, 2025, 4:41 PM EDT
IMDX Market Cap
IMDX has a market cap or net worth of $74.36 million as of August 1, 2025. Its market cap has increased by 69.00% in one year.
Market Cap
74.36M
Enterprise Value
44.17M
1-Year Change
69.00%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since January 4, 2016, IMDX's market cap has decreased from $228.70M to $74.36M, a decrease of -67.49%. That is a compound annual growth rate of -11.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 72.10M | 79.80% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
| Jan 4, 2016 | 228.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.68B |
| Johnson & Johnson | 400.65B |
| AbbVie | 343.44B |
| AstraZeneca | 236.88B |
| UnitedHealth Group | 229.90B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.67B |
| Novo Nordisk | 221.96B |